Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
- 30 November 2007
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 85 (2), 178-186
- https://doi.org/10.1016/j.radonc.2007.07.003
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Clinical impact of FDG‐PET/CT in the planning of radiotherapy for early‐stage Hodgkin lymphomaEuropean Journal of Haematology, 2006
- Cancer Stem CellsThe New England Journal of Medicine, 2006
- Combined-Modality Therapy Versus Radiotherapy Alone for Treatment of Early-Stage Hodgkin's Disease: Cure Balanced Against ComplicationsJournal of Clinical Oncology, 2006
- FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaBlood, 2006
- [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeBlood, 2005
- Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphomaRadiotherapy and Oncology, 2004
- Is there any future in radiotherapy planning without the use of PET: unraveling the myth…Radiotherapy and Oncology, 2004
- Tissue repair and stem cell renewal in carcinogenesisNature, 2004
- Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s DiseaseJournal of Clinical Oncology, 2003